Renal Cell Carcinoma Treatment Regimens
Access a treatment regimen chart with detailed information for renal cell carcinoma, including tyrosine kinase inhibitors and cytokine therapy.
Genitourinary Cancer
Testicular Cancer Treatment Regimens
Get the latest treatment regimens for testicular cancer, including options such as carboplatin, EP + cisplatin, BEP, and VIP.
Prostate Cancer Treatment Regimens
Find detailed treatment options for prostate cancer, including clinical trials and anticancer agents such as docetaxel, prednisone, and sipuleucel-T.
Bladder Cancer Treatment Regimens
View a cancer treatment regimen chart for bladder cancer, including recommended neoadjuvant and adjuvant chemotherapy options.
Durvalumab for the Management of Urothelial Carcinoma: A Short Review on the Emerging Data and Therapeutic Potential
A review of durvalumab, an immune checkpoint inhibitor approved for the treatment of urothelial carcinoma.
Adjuvant Radiation Therapy Beneficial in Advanced UTUC
Radiation therapy administered after surgery for advanced upper tract urothelial carcinoma improves cancer-specific and distant metastasis-free survival, a study found.
Overactive Bladder Linked to Prostate Cancer ADT
Compared with men receiving androgen deprivation therapy for prostate cancer, healthy men had a 98% decreased risk of overactive bladder, study finds.
Clinician Opinion Somewhat Favors Use of Shared Decision-making in Older Men with Metastatic Castration-Resistant Prostate Cancer
This survey assessed the opinions of oncologists, urologists, and oncology nurses on the use of shared decision-making in older men with metastatic castration-resistant prostate cancer.
All-Grade AE Profiles Better Measure of Quality of Life in Metastatic Castration-Naïve Prostate Cancer
A study evaluating patient vs clinician reports of adverse events reveals which measures provide a more accurate perspective on patient quality of life.
No Decrease in Pulmonary, Surgical Outcomes With Bleomycin in Good-Risk Germ Cell Cancers
Researchers investigated whether bleomycin posed concerns regarding pulmonary or operative outcomes following PC-RPLND in men treated with chemotherapy for IGCCCG good-risk germ cell cancers.
